Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Phreesia stock

Own Phreesia stock in just a few minutes.

Fact checked

Phreesia, Inc is a health information services business based in the US. Phreesia shares (PHR) are listed on the NYSE and all prices are listed in US Dollars. Phreesia employs 532 staff and has a trailing 12-month revenue of around USD$139.7 million.

How to buy shares in Phreesia

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Phreesia. Find the stock by name or ticker symbol: PHR. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Phreesia reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Phreesia, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Phreesia. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Phreesia share price

Use our graph to track the performance of PHR stocks over time.

Phreesia shares at a glance

Information last updated 2021-02-24.
52-week rangeUSD$16.01 - USD$81.592
50-day moving average USD$67.883
200-day moving average USD$45.6256
Wall St. target priceUSD$67.36
PE ratio 2.9116
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-35.448

Buy Phreesia shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Gold/Commodities
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
Stocks, Bonds, Options
$0 + $0.65/contract, $1 minimum
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Stocks, Options, Cryptocurrency
Stocks & ETFs: $1/contract to open, $0 to close, $10 max/leg
Futures: $2.50/contract to open, $0 to close
Get 100 shares of stock (worth $1 to $6 a share)
Open and fund a new cash or margin account with $2,000+
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
$0 for US stocks
Stocks, Options, ETFs
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Phreesia stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is Phreesia under- or over-valued?

Valuing Phreesia stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Phreesia's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Phreesia's P/E ratio

Phreesia's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 3x. In other words, Phreesia shares trade at around 3x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Phreesia financials

Revenue TTM USD$139.7 million
Gross profit TTM USD$80.1 million
Return on assets TTM -5.58%
Return on equity TTM -12.29%
Profit margin -16.37%
Book value $6.123
Market capitalisation USD$2.9 billion

TTM: trailing 12 months

Shorting Phreesia shares

There are currently 1.7 million Phreesia shares held short by investors – that's known as Phreesia's "short interest". This figure is 0.4% down from 1.7 million last month.

There are a few different ways that this level of interest in shorting Phreesia shares can be evaluated.

Phreesia's "short interest ratio" (SIR)

Phreesia's "short interest ratio" (SIR) is the quantity of Phreesia shares currently shorted divided by the average quantity of Phreesia shares traded daily (recently around 472649.59128065). Phreesia's SIR currently stands at 3.67. In other words for every 100,000 Phreesia shares traded daily on the market, roughly 3670 shares are currently held short.

However Phreesia's short interest can also be evaluated against the total number of Phreesia shares, or, against the total number of tradable Phreesia shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Phreesia's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 Phreesia shares in existence, roughly 40 shares are currently held short) or 0.0494% of the tradable shares (for every 100,000 tradable Phreesia shares, roughly 49 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Phreesia.

Find out more about how you can short Phreesia stock.

Phreesia share dividends

We're not expecting Phreesia to pay a dividend over the next 12 months.

Phreesia overview

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company's Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments. It deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a Web-based dashboard for providers; PhreesiaPads, which are self-service intake tablets; and Arrivals Stations that are on-site kiosks. The company's Phreesia Platform also provides a registration solution to automate patient self-registration; patient activation solution that enables providers to communicate with their patients through surveys, announcements, messaging, and health campaigns; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, and cost estimation tools; clinical support solution that collects clinical intake and PRO data for approximately 25 specialties; appointments solution for online appointments, reminders, and referral tracking; and life sciences solution to deliver targeted and clinically relevant marketing content to patients. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and life sciences, pharmaceutical, medical device, and biotechnology companies. Phreesia, Inc. has a strategic alliance agreement with Allscripts Healthcare, LLC. The company was founded in 2005 and is headquartered in New York, New York.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site